Using an SMS to improve bowel cancer screening: the acceptability and feasibility of a multifaceted intervention.

ABSTRACT:

Background

The Australian National Bowel Cancer Screening Program sends an immunochemical faecal occult blood test to Australians aged 50-74 years to screen for bowel cancer, but uptake is low (40.9%). The SMARTscreen trial demonstrated that sending a short messaging services (SMS) prompt from the participant's general practitioner (GP) increased the proportion of kit returns by 16.5%. This research aimed to determine the acceptability and feasibility of implementing SMARTscreen.

Method

SMARTscreen was a cluster randomized controlled trial set in 21 Australian general practices in regional Australia. Participants and general practice staff involved in the trial were included in this study. Acceptability and feasibility were measured quantitatively by calculating proportions

SUBMITTER: McIntosh JG 

PROVIDER: S-EPMC11770820 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature